Loading the section
Prices delayed by 15 minutes
Next earnings report: 02 November 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Bruker Corporation trades on Nasdaq under the ticker BRKR. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks BRKR has traded between 32.37 $ and 66.98 $. As of 09 October 2026 the price stood 73.82 % of the way from the 52-week low to the high.
Over one year BRKR shares rose 67.59 %; over six months they rose 52.50 %. Volatility over 90 days is 67.49 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 1.0, below the sector median of 3.9. Price to book is 1.3, below the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 59.23 | 59.23 | 56.29 | 57.92 | 3M |
| 07 October 2026 | 60.85 | 61.38 | 57.33 | 59.72 | 3M |
| 06 October 2026 | 64.67 | 66.42 | 59.30 | 60.50 | 3M |
| 05 October 2026 | 63.12 | 64.48 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
The issuer has several share classes — market cap covers the whole company.
Bruker Corporation (BRKR) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 3.4bn $, net income was -8.6m $. Distributions over the trailing twelve months were 0 $ per share. Payouts have run for 10 consecutive years. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:40 MANNING RD, BILLERICA, MA, 01821, US
Bruker Corporation reported revenue of 3.5B $ and a net loss of 12M $ over the last four quarters. Net margin is −0.34 %. Revenue changed by +0.36 % year over year. Earnings per share are −0.24 $. Market capitalisation is 3.3B $.
BRKR has a return on equity of −0.47 %, above the sector median of −41.68 %. Return on assets is −0.19 %, above the sector median of −32.11 %. Operating margin is 1.35 %, above the sector median of −26.84 %.
Bruker Corporation pays dividends quarterly: 0.20 $ per share over the past twelve months, a yield of 0.35 %. The latest payment was 0.0500 $, with an ex-dividend date of 21 September 2026.
| 303M |
| MTDMettler-Toledo International, Inc. | 1,550 | +1.34 % | 295M |
| TXG10x Genomics, Inc. | 80.65 | +4.36 % | 269M |
| AVTRAvantor, Inc. | 15.67 | +1.82 % | 130M |
| BIOBio-Rad Laboratories, Inc. | 366.16 | +1.60 % | 98M |
| 62.65 |
| 63.86 |
| 2M |
| 02 October 2026 | 62.25 | 64.36 | 62.25 | 63.24 | 2M |
| 01 October 2026 | 64.30 | 64.82 | 61.70 | 61.94 | 2M |
| 30 September 2026 | 64.32 | 66.98 | 63.86 | 64.75 | 2M |
| 29 September 2026 | 63.61 | 64.79 | 62.44 | 64.51 | 2M |
| 28 September 2026 | 63.22 | 64.95 | 62.37 | 63.28 | 3M |
| 25 September 2026 | 64.33 | 65.26 | 62.38 | 64.18 | 3M |
| 24 September 2026 | 59.17 | 65.00 | 59.17 | 64.00 | 2M |
| 23 September 2026 | 60.70 | 62.59 | 59.37 | 59.67 | 2M |
| 22 September 2026 | 62.29 | 62.47 | 60.91 | 61.21 | 2M |
| 21 September 2026 | 62.05 | 62.67 | 60.57 | 61.58 | 2M |
| 18 September 2026 | 63.37 | 63.49 | 60.40 | 61.39 | 3M |
| 17 September 2026 | 61.90 | 64.42 | 61.30 | 63.05 | 3M |
| 16 September 2026 | 56.64 | 61.72 | 56.61 | 60.67 | 4M |
| 15 September 2026 | 52.87 | 56.34 | 52.86 | 55.75 | 3M |
| 14 September 2026 | 53.11 | 53.62 | 51.54 | 52.66 | 3M |
| 11 September 2026 | 53.77 | 54.33 | 53.08 | 53.43 | 2M |